ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages BioMarin Pharmaceutical Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action
/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN)...